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Abstract 
Performance of neural network models relies on the availability of large datasets            
with minimal levels of uncertainty. Transfer Learning (TL) models have been           
proposed to resolve the issue of small dataset size by letting the model train on a                
bigger, task-related reference dataset and then fine-tune on a smaller,          
task-specific dataset. In this work, we apply a transfer learning approach to            
improve predictive power in noisy data systems with large variable confidence           
datasets. We propose a deep neural network method called ​Filtered Transfer           
Learning (FTL) that defines multiple tiers of data confidence as separate tasks in             
a transfer learning setting. The deep neural network is fine-tuned in a hierarchical             
process by iteratively removing (filtering) data points with lower label confidence,           
and retraining. In this report we use FTL for predicting the interaction of drugs              
and proteins. We demonstrate that using FTL to learn stepwise, across the label             
confidence distribution, results in higher performance compared to deep neural          
network models trained on a single confidence range. We anticipate that this            
approach will enable the machine learning community to benefit from large           
datasets with uncertain labels in fields such as biology and medicine. 
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1 Introduction 
The availability of large domain-specific datasets has made it possible for the corresponding             
industries and scientific communities to benefit from deep neural network modeling in target             
tasks. The complexity of neural network models necessitates collection of massive numbers of             
data points having both feature and output values for supervised learning tasks. Increasing             
dataset size can result in improvements in performance of machine learning (including neural             
network) models ​(Crichton et al. 2017; Jaehoon Lee, Yasaman Bahri, Roman Novak, Samuel S.              
Schoenholz, Jeffrey Pennington, Jascha Sohl-Dickstein 2018)​. Although there could be a limit to             
performance improvement gained by increasing dataset size, consistently improving         
performance is still observed from increases in dataset size when using deep neural network              
models ​(Jaehoon Lee, Yasaman Bahri, Roman Novak, Samuel S. Schoenholz, Jeffrey           
Pennington, Jascha Sohl-Dickstein 2018)​. Although large datasets for supervised learning tasks           
have become available in many domains, not all data points have the same level of confidence                
regarding the truth of their assigned labels. 
 
Although output values (either categorical, for classification, or continuous, for regression) are            
available for each data point in most datasets, the confidence level for output values need not                
be the same. In aggregated data environments, confidence in the individual data points may              
vary in a quantifiable manner by primary data source or measurement type. For example,              
consider a critical task in the pharmaceutical industry and biomedical research community:            
developing machine learning models for predicting the interaction of proteins and drugs. These             
models rely on datasets like STITCH ​(Szklarczyk et al. 2016)​, which aggregate interactions from              
multiple primary sources and report confidence values based on a composite approach to             
defining certainty ​(Szklarczyk et al. 2016)​. Differences in label confidence make model building             
challenging, as the optimization cannot be done while amalgamating all the data points in the               
training process. The challenge of mixed confidence training data is not restricted to the domain               
of protein and drug interaction; in practice, data labeling is done based on either computational               
algorithms or human experts (or even non-experts), and neither approach is perfect. Other             
examples with differences in data point label confidence include: radiological or           
histopathological images or image segment labels ​(Brady 2017; Oakden-Rayner 2020)​, and           
measured resistance to cancer drugs ​(Hafner et al. 2016)​. 
 
Extracting benefit from data points that have variable confidence regarding their true labels is a               
challenging task at best. This problem has been tackled previously using confidence based             
weight-assignment in the optimization process ​(Reamaroon et al. 2019; Almeida et al. 2020;             
Hagenah, Leymann, and Ernst 2019; Luo, Dang, and Chen 2017)​. However, some systems             
may be constrained from using weight-based strategies, such as: those with discrete confidence             
tiers rather than continuous probabilities, systems with only partial confidence assignments, or            
systems using simulated random negatives. A good example of such cases is the interaction of               
drugs and proteins. There are large datasets like STITCH ​(Szklarczyk et al. 2016) containing              
millions of data points that can be treated as positive labels (true interactions). While true               
negative data points are not as readily available, they can be randomly generated as a subset of                 
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all possible drug-protein interactions that are not reported as positives in STITCH. In this case,               
the negatives do not have any associated confidence, demonstrating a need for an alternative              
approach for handling variable confidence data points during model training. 
 
Here we propose a new modeling technique called Filtered Transfer Learning (FTL) to benefit              
from variable confidence data points. FTL is a step-wise transfer learning method for learning              
across confidence distributions, building on the already established concept of transfer learning            
(Yosinski et al. 2014)​. To illustrate key principles of the approach, the Filtered Transfer Learning               
was applied to a sample system for predicting drug-target interactions.  
 
2 Datasets 
 
The source dataset of drug-target interactions was retrieved from STITCH v5.0 using the             
web-based interface, selecting human-only interactions and the complete STITCH v5.0          
compounds dataset, with 15,473,939 and 116,224,359 records respectively ​(Szklarczyk et al.           
2016)​. Only compounds (“drugs”) with known human interactions (786,494) were parsed and            
featurized using RDKIT morgan2 circular fingerprints with 1024 bits [version 2018.9.1] ​(Landrum            
et al. 2020)​; 52 compounds were excluded due to errors in the featurization step. A snapshot of                 
reviewed protein records (“targets”) corresponding to the human canonical proteome          
(up000005640) was retrieved from uniprot on February 18th, 2020 ​(“UniProt: A Worldwide Hub             
of Protein Knowledge” 2019)​. The STITCH v5.0 interactions were mapped to 13,900            
corresponding uniprot proteins via their String IDs. Among the mapped proteins were 5508             
distinct Pfam domains ​(El-Gebali et al. 2019)​. Simple feature bit vectors were created for each               
protein by vectorizing the presence/absence of each Pfam domain in accordance with a             
fixed-length index, a strategy previously-described by Secure-DTI ​(Hie, Cho, and Berger 2018)​.            
The resulting datasets had 786,442 distinct compound bit vectors (1024-bits), 13,900 distinct            
protein bit vectors (5508-bits), and 12,152,512 filtered pairwise interactions with variable           
(labeled) confidence scores provided by STITCH v5.0. Features for positive training examples            
were obtained by concatenating the corresponding compound and protein bit vectors of the             
filtered pairwise interactions, while negative training examples were obtained by randomly           
selecting compound-protein pairs and concatenating their respective bit vectors if the pair is not              
already a positive interaction. Further details, including the data processing scripts and all             
derived bit vectors are available in the associated GitHub repository. 
 
3 Methods 
 
3.1 Dimensionality reduction 
The binary features (bit vectors) of protein and chemical space are reduced to 128 and 64 latent                 
variables using variational autoencoders. The variational autoencoders are fully connected          
neural networks with [2048, 512, 128] and [256, 128, 64] encoder architectures for protein and               
chemical space, respectively (Table 1). Both were optimized using the Adam optimizer for 500              
epochs (convergence) (Table 1). 
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Table 1​. Details of variational autoencoder models used to define separate latent spaces for              
protein and chemical space. 
Model hyperparameters Protein space Chemical space 
Total number of data points 13,900 786,442 
Number of input features 5508 1024 
Encoder layers (fully connected) [2048, 512, 128] [256, 128, 64] 
Number of epochs 500 500 
Batch size 1000 1000 
Optimization algorithm Adam Adam 
Learning rate 0.0001 0.0001 
 
3.2 Neural network model for drug-protein interaction 
The latent space representations of drugs and proteins were used as the input feature              
space in a fully connected feed-forward neural network architecture: 192 features (128            
and 64 latent variables of proteins and drugs, respectively), are used in an architecture              
of [128, 64, 32, 16, 8] fully connected layers for binary prediction of interaction between               
drugs and proteins. The Adam optimization algorithm ​(Kingma and Ba 2014) with a             
learning rate of 0.001 was used to optimize the neural network model.  
 
3.3 Filtered Transfer Learning  
Filtered Transfer Learning (FTL) is defined as a neural network trained across confidence             
distributions in a stepwise process (Figure 1). The neural network is first trained in the lower                
confidence part of the dataset, which includes the majority of the data points, and then               
continues to be trained on the higher confidence part of the dataset after filtering out the lower                 
confidence data points (Figure 1). The preliminary training on the low confidence data points              
can also be done in multiple steps ((n+1)-step FTL; n: number of steps in low confidence data).  
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Figure 1​. Schematic representation of learning stepwise across label confidence distributions           
by Filtered Transfer Learning (FTL).  
 
4 Results 
To study the performance of our proposed technique, Filtered Transfer Learning (FTL), we used              
prediction of drugs and proteins as the target task. Initially, the dimensionality of protein and               
chemical spaces were reduced using variational autoencoders (Table 1), which reduced           
computational cost and complexity for the supervised modeling using FTL. The identified latent             
variables were used for the supervised modeling throughout this study. 
 
The STITCH dataset reports a confidence score for each record of a drug/protein interaction.              
We used the highest confidence range of this score [900, 1000) as the validation set throughout                
the manuscript and split the rest to assess performance of supervised models. The confidence              
range of [700, 900) has been also reported by STITCH as the high confidence range               
(Szklarczyk et al. 2016)​. Based on this, validation performance was assessed for a neural              
network model with [128, 64, 32, 16, 8] layer sizes trained on [700, 900), as well as for models                   
trained on lower confidence ranges, chosen based on percentiles in the confidence distribution             
(Table 2; Figure 3A). The models reached convergence after 200 epochs (Figure 3B). Their loss               
(Figure 3B) and accuracy (Figure 3C) on the validation set were compared. The best validation               
loss and accuracy of the model trained on the high confidence range [700, 900) performed               
better than the models trained on lower confidence ranges (Table 3).  
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Figure 2​. Loss (A, C) and Loss Change (B, D) per epoch for optimization of the designed                 
variational autoencoder to reduce dimensionality of protein (C, D) and chemical (A, B) space. 
 
 
Table 2​. STITCH score cutoffs considered for training the neural network models used for              
predicting high confidence interactions (score: [900, 1000)) between drug/protein pairs in the            
STITCH database. 
Cutoff range for confidence of positive 
interactions in STITCH database 
Corresponding 
percentile range  
Number of positive data 
points (interactions) 
[319,900) [82,100) 2,186,942 
[389,900) [90,100) 1,204,936 
[700,900) [98,100) 249,278 
 
To assess whether FTL can improve the performance of the neural network modelling, 2-step              
FTLs were developed using the [700,900) positive label confidence range for the second             
training step. Using the [319, 700) positive label confidence range as the first step of the FTL                 
model training resulted in lower loss (5.203e-5) and higher accuracy (79.759) compared to the              
neural network model trained only on the [700, 900) confidence range (Figure 4; Table 3 and 4).                 
The confidence range of [319, 700) was then split into two equal parts by number of data                 
points, and two other 2-step FTLs were trained using the resulting ranges of [319, 389) and                
[389, 700). Both new FTLs outperformed the model trained only on the [700, 900) confidence               
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range (Figure 4; Table 3 and 4). However, the FTL with [389, 700) as the first step had lower                   
loss and higher accuracy (loss=5.317e-5; accuracy =79.203; Table 4) compared to the FTL with              
the lower confidence range of [319, 389) for training the first step (loss=5.424e-5; accuracy              
=78.549; Table 4)​. 
 
Figure 3​. (A) Positive label confidence range used in training a neural network model to predict                
the positive interactions with the label confidence score range of [900, 1000). (B) Validation loss               
and (C) accuracy of the neural network models trained on their corresponding label confidence              
range shown in panel (A). 
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Table 3​. Validation loss and accuracy of the neural network model trained on specified positive               
label confidence range in each row and validated on [900, 1000) positive label confidence              
range. 
Training confidence range Validation loss Validation accuracy (%) 
[319,900) 5.943e-5 76.444 
[389,900) 5.824e-5 77.321 
[700,900) 5.673e-5 77.874 
 
In the transition from step one to step two in the training of two-step FTLs, only the neural                  
network weights were left as available degrees of freedom. To better understand the difference              
between the two steps of the FTLs, we identified the Euclidean distance (normalized to the               
number of weights) between weights of each layer at the end of 100 epochs of training in step                  
one of the FTL and after initial 20 epochs of training in step 2 (Figure 5). We then compared                   
these distances with the distances of weights of layers after 100 and 120 epochs of training                
using the same confidence range used for step 1 of the 2-step FTL (Figure 5). This comparison                 
revealed that the network continues changing the weights of the first 2 layers in its training going                 
from step 1 to step 2 while it drastically slows down the rate of change in the weights of last 3                     
layers in this transition (Fold change < 0.55; Figure 5).  
 
Table 4​. Validation loss and accuracy of the 2-step FTLs trained on specified positive label               
confidence ranges and validated on the [900, 1000) positive label confidence range. 
Training confidence range Validation loss Validation accuracy (%) 
[319,700)->[700, 900) 5.203e-5 79.759 
[389,700)->[700, 900) 5.317e-5 79.203 
[319,389)->[700, 900) 5.424e-5 78.549 
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Figure 4​. (A) Positive label confidence range used in training a neural network model for               
predicting the positive interactions with the label confidence score range of [900, 1000).             
Validation (B) loss and (C) accuracy of the FTL trained first on label confidence ranges of either                 
[319,700), [389, 700) or [319, 389) for 100 epochs, as shown in (A), then trained for another 100                  
epochs on the positive interactions with the label confidence range of [700, 900). The horizontal               
dashed lines depict the best validation loss (B) or accuracy (C) of neural network models trained                
only on one label confidence range [700, 900) (Table 3).  
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Figure 5​. Distance between the weights of layers of neural network models either between              
epochs 100-120 of the network trained on one confidence range or between epoch 100 of step                
1 and epoch 20 of step 2 in 2-step FTL. (A) Confidence range: [319, 700) (orange); 2-step FTL:                  
[319,700)->[700,900) (red); (B) Confidence range: [389, 700) (orange); 2-step FTL:          
[389,700)->[700,900) (red). 
 
Limitations of this study​. Although the proposed model in this study (Filtered Transfer             
Learning) provides promising results for predicting drug-target interactions, we acknowledge          
that the study has some limitations: 
1) Since the developed variational autoencoder models for protein and chemical space are            
not optimized across hyperparameter space, overall performance likely could still be           
improved. However, as the same latent variables are used for the training of each neural               
network model, the identified latent variables helped us to lower computational cost of             
the study without uniquely favoring FTL or non-FTL models.  
2) The results associated with different label confidence range cutoffs cannot be applied            
directly to other datasets. For example, in the case of image label confidence, the target               
dataset  should be explored to determine appropriate cutoffs to build the training sets. 
3) The optimal number of epochs for each label confidence range in FTL should be              
identified (eg. through a grid search) which was not explored in this study. 
4) There is no correction for compound-series bias in the validation test set( i.e. the              
performance measures may be an overestimate because of very similar compounds in            
training and validation sets). 
 
Nonetheless, while the specific models presented in this study are not optimized for practical              
applications, we believe this sample system clearly demonstrates the application of a Filtered             
Transfer Learning towards improving predictive performance on variable confidence data          
systems. 
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5 Conclusion 
Noisy datasets are commonplace among practical systems that apply deep learning strategies.            
Optimizing performance of real-world predictions requires the modelling system to maximize the            
value of all available data. While noisier data may contain incorrect entries, the presence of a                
predictive signal indicates a net-positive informational value. Strategies for dealing with           
variable-confidence training data present an alternative to data sanitization techniques that           
exclude noisier data in bulk, and thus discard useful information. However, many such             
strategies, like ensemble learning or training weights, may impose functional disadvantages or            
technical constraints, limiting their overall practicality.  
 
We proposed a new approach called Filtered Transfer Learning (FTL) to benefit from data              
points with variable label confidence while training a neural network. FTL is trained across label               
confidence distributions in a stepwise manner starting from low confidence and moving to high              
confidence data points (with or without overlapping data points across the steps). We             
demonstrate the utility of our approach using a dataset for predicting interactions between drugs              
and proteins, a matching problem with sparsely populated positive examples, a lack of explicit              
negative examples, and defined label confidence. The presented results show higher           
performance for FTL when compared to neural network models trained on the data points with               
different label confidence levels in a single step. To study the effect of label confidence on the                 
trained neural networks, we compared the weights of neural networks between the steps of FTL               
models. The weights of the first layers including the weights connecting the input layer to the                
first hidden layer kept changing while changes in the last layers slowed down dramatically              
during transition between the steps in FTL models. By presenting a new deep learning strategy               
for dealing with variable confidence training data, we challenge the data ​quality vs quantity              
tradeoff. The Filtered Transfer Learning has minimal additional technical constraints and           
leverages the breadth of larger datasets, without diluting the impact of richer training examples. 
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